Influence of α-Particle Radiation on Intercellular Communication Networks of Tunneling Nanotubes in U87 Glioblastoma Cells.
bystander effect
cancer
cellular communication
glioblastoma
high-LET
tunneling nanotubes
Journal
Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867
Informations de publication
Date de publication:
2020
2020
Historique:
received:
20
05
2020
accepted:
29
07
2020
entrez:
5
10
2020
pubmed:
6
10
2020
medline:
6
10
2020
Statut:
epublish
Résumé
Cellular communication plays a crucial role in the coordination and organization of cancer cells. Especially processes such as uncontrolled cell growth, invasion, and therapy resistance (development), which are features of very malignant tumors like glioblastomas, are supported by an efficient cell-to-cell communication in the tumor environment. One powerful way for cells to communicate are tunneling nanotubes (TNTs). These tiny membrane tunnels interconnect cells over long distances and serve as highways for information exchange between distant cells. Here, we study the response of cellular communication via TNTs in U87 glioblastoma cells to homogeneous irradiation with α-particles as a stress factor. We describe the development of TNT networks in certain time steps after irradiation using confocal live-cell imaging and suggest an evaluation method to characterize these communication networks. Our results show that irradiated cells establish their network faster and have more cell-to-cell connections with high TNT content than sham-irradiated controls within the first 24 h. These findings suggest that there is an additional trigger upon radiation damage which results in fast and intensive network formation by TNTs as a radiation damage response mechanism.
Identifiants
pubmed: 33014842
doi: 10.3389/fonc.2020.01691
pmc: PMC7509401
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1691Informations de copyright
Copyright © 2020 Matejka and Reindl.
Références
Brain. 2007 Oct;130(Pt 10):2596-606
pubmed: 17785346
J Neurooncol. 2018 Sep;139(3):583-590
pubmed: 29882045
Cancers (Basel). 2018 Nov 20;10(11):
pubmed: 30463322
Nat Rev Cancer. 2009 May;9(5):351-60
pubmed: 19377507
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
Front Cell Dev Biol. 2018 Oct 02;6:95
pubmed: 30333973
J Neurooncol. 2004 Nov;70(2):217-28
pubmed: 15674479
Nature. 2015 Dec 3;528(7580):93-8
pubmed: 26536111
J Immunol. 2008 May 1;180(9):5779-83
pubmed: 18424694
Oncotarget. 2016 Jul 12;7(28):43150-43161
pubmed: 27223082
Int J Radiat Biol. 2010 Aug;86(8):682-91
pubmed: 20569192
Open Biol. 2016 Jun;6(6):
pubmed: 27278648
Proc Natl Acad Sci U S A. 2010 Oct 5;107(40):17194-9
pubmed: 20855598
Front Cell Dev Biol. 2016 Sep 28;4:107
pubmed: 27734015
Cell Stress Chaperones. 2019 Jan;24(1):213-221
pubmed: 30632067
J Cell Sci. 2012 Mar 1;125(Pt 5):1089-98
pubmed: 22399801
Nat Cell Biol. 2008 Feb;10(2):211-9
pubmed: 18193035
PLoS One. 2011;6(12):e29537
pubmed: 22216308
Science. 2004 Feb 13;303(5660):1007-10
pubmed: 14963329
Cell Immunol. 2009;254(2):142-8
pubmed: 18835599
Cell Cycle. 2018;17(6):712-721
pubmed: 29582715
Nat Genet. 2001 Mar;27(3):247-54
pubmed: 11242102
Radiat Oncol. 2019 Dec 3;14(1):218
pubmed: 31796110
Cancer Rep (Hoboken). 2019 Dec;2(6):e1185
pubmed: 32729189
Front Mol Neurosci. 2017 Oct 17;10:333
pubmed: 29089870
Cancer. 2005 Sep 15;104(6):1129-37
pubmed: 16080176
J Neurosurg. 2016 Apr;124(4):998-1007
pubmed: 26452121
Biochim Biophys Acta. 2012 Aug;1818(8):2082-6
pubmed: 21930113
Front Physiol. 2014 Oct 31;5:400
pubmed: 25400582
J Cell Sci. 2005 Aug 15;118(Pt 16):3695-703
pubmed: 16046474
Cell Death Differ. 2015 Jul;22(7):1181-91
pubmed: 25571977
PLoS One. 2012;7(3):e33093
pubmed: 22427958
Int J Med Sci. 2012;9(3):193-9
pubmed: 22408567
Int J Nanomedicine. 2011;6:495-509
pubmed: 21468353